Recombinant HIV-1 Envelope Proteins and Their Use
Copyright © Targeted News Service 2024
2024-11-19
ALEXANDRIA, Virginia, Nov. 19 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, Bethesda, Maryland has been assigned a patent (No. US 12145968 B2, initially filed Oct. 3, 2022) developed by sixteen inventors Peter Kwong, Washington, District of Columbia; Marie Pancera, Seattle, Washington; Tongqing Zhou, Boyds, Maryland; Ivelin Georgiev, Nashville, Tennessee; Michael Gordon Joyce, Washington, District of Columbia; Priyamvada Acharya, Chape . . .